Trinity Biotech (TRIB) FCF Payout Ratio (2015)

Trinity Biotech (TRIB) posted quarterly FCF Payout Ratio of 3.61 for Q4 2015.

Trinity Biotech (TRIB) FCF Payout Ratio (2015) Analysis & Trends

Trinity Biotech (TRIB) has reported FCF Payout Ratio for 1 consecutive years, with 3.61 the latest figure, recorded in Q4 2015.

  • Quarterly FCF Payout Ratio changed N/A year-over-year to 3.61 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was 0.02 (down 101.78% YoY) and the FY2015 annual result came in at 0.79, up 483.92% from the prior year.
  • FCF Payout Ratio held at 3.61 in Q4 2015 per TRIB's latest filing.
  • Over the last five years, FCF Payout Ratio for TRIB reached as high as 3.61 in Q4 2015 and fell as low as 3.61 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.20
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.81
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.44
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.14
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Trinity Biotech 93,750.00 -5.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2015 -3.61